` 600222 (Henan Taloph Pharmaceutical Stock Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

600222
vs
S
Shanghai Composite

Over the past 12 months, Henan Taloph Pharmaceutical Stock Co Ltd has outperformed Shanghai Composite, delivering a return of +24% compared to the Shanghai Composite's +23% growth.

Stocks Performance
600222 vs Shanghai Composite

Loading
600222
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
600222 vs Shanghai Composite

Loading
600222
Shanghai Composite
Difference
www.alphaspread.com

Performance By Year
600222 vs Shanghai Composite

Loading
600222
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Henan Taloph Pharmaceutical Stock Co Ltd vs Peers

Shanghai Composite
600222
JEF
JNJ
4312
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Henan Taloph Pharmaceutical Stock Co Ltd
Glance View

Market Cap
3.8B CNY
Industry
Pharmaceuticals

Henan Taloph Pharmaceutical Stock Co., Ltd. engages in the pharmaceutical manufacturing industry. The company is headquartered in Zhengzhou, Henan and currently employs 2,209 full-time employees. The firm provides oral solutions, transfusion and tablets, which are applied in the treatment of cold, diabetes and virus infection. The firm's main products include Shuanghuanglian oral liquid products, double gold agents, Haberffine tablets and compound Yimu oral solutions, among others. The firm distributes its products mainly within domestic market.

Intrinsic Value
4.33 CNY
Overvaluation 35%
Intrinsic Value
Price
Back to Top